Abstract
Clinical stage (c-stage) at diagnosis is the most significant prognostic marker for patients with cancer, where 1- and 5-year survival rates as main landmarks when assessing outcomes. This is a population-based case study of Danish c-stage I lung cancer patients who were considered candidates for curative therapy and then died within 1 year after diagnosis (cases). Cases were identified in the Danish Lung Cancer Register (DLCR), and medical records were used to retrieve treatment details and cause of death (CoD). Our aims were, if possible, to identify and describe clusters of patients, in terms of CoD and treatment modality at risk for an adverse short-term outcome. Patients who died early were more frequently male, older, had squamous-cell histology, were less frequently surgically treated and generally had a higher burden of comorbidity. In terms of CoD, 29% died of lung cancer with distant recurrence (DR) as the most common type of recurrence (55%). Death from co-morbidity occurred for 23%, where the largest proportion (36%) died from another cancer. Nineteen percentage died from treatment complications, with the majority being male (p < .001). The remainder died of unknown or other causes. Lung cancer with DR remains the m...Continue Reading
References
Jan 1, 1987·Journal of Chronic Diseases·M E CharlsonC R MacKenzie
Aug 29, 2006·Diabetes·Tamara AllenThomas A Gustafson
Nov 17, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Satoshi ShionoToru Sato
Aug 4, 2011·Scandinavian Journal of Public Health·Marianne Lundkjær Gjerstorff
Nov 8, 2011·Clinics in Chest Medicine·Hiren J MehtaRoy H Decker
Dec 6, 2011·Health Policy·Helene Bilsted ProbstOle Andersen
Mar 17, 2012·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Ilker IskenderAltan Kir
May 17, 2012·World Journal of Radiology·Saeed MirsadraeeEdwin van Beek
Feb 13, 2013·Thorax·Sarah WaltersUNKNOWN ICBP Module 1 Working Group
May 10, 2013·Chest·Frank C DetterbeckW Michael Alberts
Aug 27, 2013·Lancet·Martin ReckKlaus F Rabe
Sep 21, 2013·British Journal of Cancer·S McPhailM Richards
Nov 15, 2013·Clinical Epidemiology·Thomas DeleuranMette Søgaard
Jan 25, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Erik JakobsenTorben Palshof
Mar 19, 2014·Surgical Oncology·Michael Z CaposoleThomas L Bauer
Apr 1, 2015·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Anders GreenErik Jakobsen
Oct 25, 2016·The Annals of Thoracic Surgery·David Jonathan HeinemanWilhelmina Hendrika Schreurs
Dec 23, 2016·Expert Review of Respiratory Medicine·Marjolein A HeuvelmansMatthijs Oudkerk
Jan 18, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Takashi EguchiPrasad S Adusumilli
Jul 19, 2017·World Journal of Radiology·Fernando U KayPrabhakar Rajiah
Sep 28, 2017·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Anders Standal BuggeJohny Kongerud
Citations
May 29, 2020·Acta Oncologica·Niels Lyhne ChristensenSusanne Oksbjerg Dalton
Jul 10, 2019·Acta Oncologica·Kaire InnosTiiu Aareleid
Sep 29, 2020·Acta Oncologica·Mef NilbertGiske Ursin
Jun 15, 2021·Expert Review of Anticancer Therapy·Helene GoussaultChristos Chouaïd